Taken together, our findings demonstrated that the loss of XIAP expression mediated by XIAP-specific antagonists A4 and B3—not pan-IAP antagonist BV6—is highly selective and is necessary and sufficient to induce apoptosis in high-risk neuroblastoma cells. Here, XIAP is linked to neuroblastoma.